The company said the results from the evoke study, which tested an oral semaglutide pill for early-stage symptomatic Alzheimer's disease, were "not what we had hoped for"
The pair will leverage NVIDIA's AI platform to progressively increase the automation, accuracy and speed of laboratories, helping scientists reduce manual steps and accelerate...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.